The high CBD hemp flower strain known as Special Sauce is a “special sauce” because it has an infusion of CBG. The CBG makes it unique from all other buds. The flowers are more the size of a “nug” but worthy rivals to others larger in size due to the winning potency. The dense pungency is distinct for the nugs which offer a speckling of trichomes richly over the surface.
Special Sauce Hemp Flower and CBG
The Special Sauce hemp flower strain is a high CBD, low THC variety with an infusion of CBG, creating an unusual combination. The CBD level ranges from a median of 14 to a higher 19 percent, with THC in a legal 0.3 percent, and CBG coming in at 0.61 percent.
A multitude of terpenes creates the array of scents distinct to this specific strain, including Fenchol. There are also caryophyllene, myrcene, pinene. The unique flavor comes through Farnesene, which also consists of antioxidant properties.
New to receiving attention is CBG, finding its way as the headliner in the hemp flower with this strain. It is a worthy competitor to CBD for wellness properties. At this stage, the potential is greater than the evidence available. But as was the case with CBD, anecdotal reports from users indicate a far-reaching benefit going beyond that of cannabidiol. View this to learn about CBG.
To preserve CBG in the hemp plant, harvesting must take place before the plant matures, thus the need to infuse the compound into the plant. Once infused, the nug provides added benefits.
Cannabinoids and The Hemp Plan
Claims suggest that CBG warrants a title as the “grandfather” among the other cannabinoids within the hemp bud. As with cannabidiol, the compound has regulations and legalities equal to CBD.
Manipulation of hemp can render the strain high in CBD or high THC, but plants need harvesting early to preserve the most CBG. With CBD and THC in high demand, growers tend to let the plants mature. The mature plants disallow the CBG preservation and also minimal opportunities for extraction of the compound.
Special Sauce Benefits
The properties in the Special Sauce strain render it a good option for use before bed as an aid for those with challenges in sleeping. The bud also boasts beneficial for managing pain symptoms and providing a sense of calm at the end of a long day.
The cannabinoids work together with this flower to create a most unique effect, with CBG coming out as a new potential celebrity on the tarmac. Early science indications say that the compound shows therapeutic promise with neuroprotective benefits. Other possible advantages:
- Inflammatory Bowel Disease or IBD: Bowel inflammation reduced significantly for IBD participants.
- Anticancer/Antibacterial: Early studies indicate antibacterial properties and inhibition of cancer cell growth.
- Neuroprotective: Experimentation has the compound displaying neuroprotective capacity with diseases like Huntington’s.
Research is minimal and in the infancy stages. Scientists and consumers know very little about CBG at this stage. The compound takes a back seat as growers generally manipulate the buds more towards the most common CBD and THC prevalence. That might begin to change as more research comes.
Special Sauce is the first strain of its kind, with more likely to come behind it as people begin to demand the compound. You can check out the buds online with sites like https://cheefbotanicals.com/product/cbd-hemp-flower-special-sauce/. Once word-of-mouth takes hold that CBG has an anecdotally comparable benefit, if not more so than CBD, that demand will rise quickly.
THC holds its own, always has, and likely always will. People enjoy its psychoactive quality, and none of the other cannabinoids have that trait. It is unique unto itself.
It’s wild how a cannabinoid can come on the scene to a round of accolades but then have another one come into play that may or may not go a bit beyond the first compound’s capacity, and suddenly the new kid on the block gets the spotlight.
It kind of sounds like high school friends. The bottom line is science needs to merely catch up with the research for CBD posting official evidence relating to its effectiveness, giving FDA approvals, and allowing medical providers prescription capabilities before another cannabinoid comes to town. It seems like that would make more sense.